Polyplus-transfection Lands $1.8M Financing | GenomeWeb

NEW YORK (GenomeWeb News) – Polyplus-transfection has raised €1.2 million ($1.8 million) through a new funding round from existing investors.

The Strasbourg, France-based firm said it plans to use the funding primarily for its RNAplus research program, which aims to generate new oligonucleotides that are capable of silencing the expression of a target gene through RNA interference without the need for a delivery reagent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.